NanoViricides
NNVC
32 hedge funds and large institutions have $1.24M invested in NanoViricides in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
1,950% more call options, than puts
Call options by funds: $41K | Put options by funds: $2K
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
7% more funds holding
Funds holding: 30 → 32 (+2)
0.04% more ownership
Funds ownership: 10.29% → 10.33% (+0.04%)
23% less capital invested
Capital invested by funds: $1.61M → $1.24M (-$377K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$19.4K |
| 2 |
VF
Virtu Financial
New York
|
+$19.3K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$12.9K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$2.83K |
| 5 |
Renaissance Technologies
New York
|
+$2.77K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$34K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$13.7K |
| 3 |
BlackRock
New York
|
-$1.91K |
| 4 |
FAM
Flaharty Asset Management
Clearwater,
Florida
|
-$268 |
| 5 |
TWP
TFO Wealth Partners
Maumee,
Ohio
|
-$75 |
NNVC Hedge Fund Activity: Q4 2023 in Review
32 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q4 2023, worth a combined $1.24M — down 23% from $1.61M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NNVC positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $19.4K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $34K sold.
- 32 institutional investors held NanoViricides (NNVC) as of Q4 2023, up from 30 in Q3 2023.
- Funds reported $1.24M of NanoViricides stock for Q4 2023, down 23% quarter-over-quarter.
- 7 funds opened new NanoViricides positions in Q4 2023 and 5 closed out, a net change of +2 holders.
- The largest NanoViricides buyer in Q4 2023 was Citadel Advisors, an estimated $19.4K added.
- The largest NanoViricides seller in Q4 2023 was Susquehanna International Group, an estimated $34K sold.
Based on aggregated 13F filings for Q4 2023.